Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

HIV Medicine - Tập 18 Số 4 - Trang 256-266 - 2017
Sirinya Teeraananchai1,2, Stephen J. Kerr3,1,2, Janaki Amin2, Kiat Ruxrungtham4,1, Matthew Law2
1HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand
2Kirby Institute, University of New South Wales, Sydney, NSW, Australia
3Department of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, The Netherlands
4Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Tóm tắt

ObjectivesLife expectancy is an important indicator informing decision making in policies relating to HIV‐infected people. Studies estimating life expectancy after starting combination antiretroviral therapy (cART) have noted differences between income regions. The objective of our study was to perform a meta‐analysis to assess life expectancy of HIV‐positive people after starting cART, and to quantify differences between low/middle‐ and high‐income countries.MethodsEight cohort studies estimating life expectancy in HIV‐positive people initiating cART aged ≥ 14 years using the abridged life table method were identified. Random effects meta‐analysis was used to pool estimated outcomes, overall and by income region. Heterogeneity between studies was assessed with the I2 statistic. We estimated additional years of life expected after starting cART at ages 20 and 35 years.ResultsOverall life expectancy in high‐income countries was an additional 43.3 years [95% confidence interval (CI) 42.5–44.2 years] and 32.2 years (95% CI 30.9–33.5 years) at ages 20 and 35 years, respectively, and 28.3 (95% CI 23.3–33.3) and 25.6 (95% CI 22.1–29.2) additional years, respectively, in low/middle‐income countries. In low/middle‐income countries, life expectancy after starting cART at age 20 years was an additional 22.9 years (95% CI 18.4–27.5 years) for men and 33.0 years (95% CI 30.4–35.6 years) for women, but was similar in the two sexes in high‐income countries. In all income regions, life expectancy after starting cART increased over calendar time.ConclusionsOur results suggest that the life expectancy of HIV‐positive people after starting cART has improved over time. Monitoring life expectancy into the future is important to assess how changes to cART guidelines will affect patient long‐term outcomes.

Từ khóa


Tài liệu tham khảo

WHO, 2014, WHO Methods for Life Expectancy and Healthy Life Expectancy, 1

UNAIDS.Report on the global AIDS epidemic Chapter 4: The impact of AIDS on People and Societies'2006.

UNDP.Human development report: The Rise of the South: Human Progress in a Diverse World. United Nations Development Programme. Vol 2016 2013.

10.1097/QAD.0b013e328133f285

10.1097/QCO.0b013e32835ba6b1

10.1136/sti.2010.046060

WHO, 2006, Progress on Global Access to HIV Antiretroviral Therapy. An Update on “3 by 5”, March 2006

10.1071/SH11046

10.1186/1741-7015-11-251

World Bank.Country and Lending Groups 2015. Available athttp://data.worldbank.org/about/country-and-lending-groups(accessed 15 June 2015).

10.1016/j.ijsu.2010.02.007

Chiang CL, 1972, On constructing current life tables, JASA, 67, 538, 10.1080/01621459.1972.10481245

10.1136/bmj.315.7109.629

10.1097/QAI.0000000000000018

10.1136/bmj.d6016

10.1097/QAD.0000000000000243

10.1016/S0140-6736(08)61113-7

10.1371/journal.pone.0081355

10.7326/0003-4819-155-4-201108160-00358

10.1371/journal.pmed.1001418

10.1016/S2214-109X(14)70364-X

10.7448/IAS.18.1.20261

10.1097/QAD.0b013e32802ef30c

10.1097/01.aids.0000206508.32030.92

10.1186/s12879-015-0969-x

10.1097/QAD.0000000000000540

WHO Life tables by World Bank Income Group. Available athttp://apps.who.int/gho/data/view.main.LIFEWBLMI?lang=en(accessed 24 July 2015).

WHO Life tables by country. Available athttp://www.who.int/gho/countries/en/(accessed 11 April 2016).

10.1371/journal.pmed.1001905

10.1371/journal.pmed.1001906

WHO/UNAIDS, 2013, Gobal Update on HIV Treatment 2013: Results, Impact and Opportunities

10.1086/644772

10.1097/QAD.0b013e32833a3946

10.7326/0003-4819-146-2-200701160-00003

10.1016/S2214-109X(14)70383-3

Thông tin
Thông tin xuất bản

HIV Medicine

Tập 18 Số 4

256-266

Thông tin tác giả